5-Fluorocytosine/5-Fluorouracil Drug-Drug Cocrystal: a New Development Route Based on Mechanochemical Synthesis
- 14 June 2018
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 14 (1) , 50-56
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Pharmaceutical Cocrystals of Diflunisal and Diclofenac with TheophyllineMolecular Pharmaceutics, 2014
- Drug-drug co-crystalsDARU Journal of Pharmaceutical Sciences, 2012
- Polymorphs, Salts, and Cocrystals: What’s in a Name?Crystal Growth & Design, 2012
- Coformer Selection in Pharmaceutical Cocrystal Development: a Case Study of a Meloxicam Aspirin Cocrystal That Exhibits Enhanced Solubility and PharmacokineticsJournal of Pharmaceutical Sciences, 2011
- Pharmaceutical Co-crystals with Isonicotinamide—Vitamin B3, Clofibric Acid, and Diclofenac—and Two Isonicotinamide HydratesCrystal Growth & Design, 2010
- Effects of Crystal Form on Solubility and Pharmacokinetics: A Crystal Engineering Case Study of LamotrigineCrystal Growth & Design, 2009
- Pharmaceutical Cocrystals and Their Physicochemical PropertiesCrystal Growth & Design, 2009
- Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical IngredientsCrystal Growth & Design, 2008
- Pharmaceutical Co-CrystalsJournal of Pharmaceutical Sciences, 2006
- Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine HydrationCrystal Growth & Design, 2005